Main-chain imidazolium oligomer material as a selective biomimetic antimicrobial agent.

Lihong Liu,Yuan Huang,Siti Nurhanna Riduan,Shujun Gao,Yiyan Yang,Weimin Fan,Yugen Zhang
DOI: https://doi.org/10.1016/j.biomaterials.2012.08.006
IF: 14
2012-01-01
Biomaterials
Abstract:Human health has been challenged by multi-drug-resistant microorganisms for several decades. Herein, we have developed a main-chain imidazolium oligomer (IBN-1) material to combat broad spectrum of pathogenic strains, including drug-resistant Klebsiella pneumoniae, Vancomycin-resistant enterococcus, Methicillin-resistant Staphylococcus aureus and fluconazole-resistant yeast Cryptococcus neoformans, while displaying minimal hemolysis (HC50/MIC values over 3000) and a very high therapeutic index of 37 for killing S. aureus under inflammatory conditions in vivo.
What problem does this paper attempt to address?